In Ewing sarcoma, small molecule YK-4-279 and its clinical derivative TK-216 have been labelled as first-in-class inhibitors of EWSR1::FLI1 and other EWSR1 fusions seen in Ewing sarcoma. The gene discussed is FLI1; the disease is Ewing sarcoma.